preview

Drug Therapy And Its Effects On The World

Good Essays

According to Günthard et al., "antiretroviral agents remain the cornerstone of HIV treatment. All HIV-infected individuals with detectable plasma virus should receive treatment with recommended initial regimens consisting of an InSTI plus 2 NRTIs" (2016, p.192). Current antiretroviral HIV treatments focus on blocking HIV viruses at different stages of the virus life cycles. The most common classes of medications include entry inhibitors, fusion inhibitors, reverse transcriptase inhibitors, integrase strand transfer inhibitor and protease inhibitors. Multi-drug therapy including medications from at least 2 or 3 different classes is normally used to slow the progression of the diseases and to increases life expectancy of those patients (Chereshenev et al., 2013).

The entry inhibitors were first approved by FDA in 2003 and their mechanism was to prevent the viruses from entering the target T cells. They are acting on the human CCR5 chemokine receptors to prevent viruses from attaching to the T cell, thus, avoiding entry. (Chereshenev et al., 2013). Fusion inhibitors such as enfuvirtide, are oligopeptides that prevents HIVs from entering host cells by blocking the cell fusion process (Chereshenev et al.) Nucleoside reverse transcriptase inhibitors are (NRTI) the first medication available to treat HIVs. When the viruses replicate, they have to use nucleosides to build their DNAs. Since the NRTIs chemically resemble the naturally occurring nucleosides, so when the viruses use

Get Access